Association of different restriction levels with COVID-19-related distress and mental health in somatic inpatients: a secondary analysis of Swiss... (Publications)
Background: The coronavirus disease 2019 (COVID-19) pandemic and related countermeasures hinder health care access and affect mental wellbeing of non-COVID-19 patients. There is lack of evidence on di
Epidemics of Crimean-Congo hemorrhagic fever (CCHF) in Sudan between 2010 and 2020 (Publications)
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic arboviral disease that poses a great threat to global health in the Old World, and it is endemic in Europe, Asia, and Africa, including Sudan. In t
How to incorporate lived experience into evidence-based interventions: assessing fidelity for peer-delivered substance use interventions in local and... (Publications)
Interventions led by peer recovery specialists (PRSs) have rapidly expanded in response to a global shortage of access to substance use treatment. However, there is a lack of guidance on how to incorp
Practice change needed for the identification of pediatric hypertension in marginalized populations: an example from South Africa (Publications)
Introduction:Hypertension in children has increased globally over the past 20 years; yet, little is known about this issue among disadvantaged communities from low- and middle-income countries. Age-,
Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral... (Publications)
INTRODUCTION: HIV programmes across many countries in Africa have recently transitioned people living with HIV from efavirenz (EFV)- to dolutegravir (DTG)-containing antiretroviral therapy (ART). As b
Treatment outcome of imported cutaneous leishmaniasis among travellers and migrants infected with<em> Leishmania major</em> and <em>Leishmania... (Publications)
OBJECTIVES: Cutaneous leishmaniasis (CL) in Asia, Northern and Sub-Saharan Africa is mainly caused by Leishmania major and Leishmania tropica. We describe and evaluate the treatment outcome of CL amon
Parasite viability as a measure of <em>in vivo</em> drug activity in preclinical and early clinical antimalarial drug assessment (Publications)
The rate at which parasitemia declines in a host after treatment with an antimalarial drug is a major metric for assessment of antimalarial drug activity in preclinical models and in early clinical tr
Priority setting in early childhood development: an analytical framework for economic evaluation of interventions (Publications)
BACKGROUND: Early childhood development (ECD) sets the foundation for healthy and successful lives with important ramifications for education, labour market outcomes and other domains of well-being. E
